The German Medical Journal notes in a recent message to the PLoS Medicine published towards study, which was studied in such an impact on visits by pharmaceutical representatives, the prescription behavior. The results are sobering. Be
"After the speakers visitors said 36 percent of doctors that seek to prescribe the drug in the future more often Stimulating has in the opinion of the first author Michael Steinman of the Veterans Hospital in San Francisco had an impact that the pharmaceutical representatives at 39 percent of visits to doctors drug samples duties. In 38 percent of visits had at least made the pharmaceutical representatives an off-label use to the main theme of the visit, which is prohibited under U.S. law, even if the initiative should be considered by the physician. "(DÄB)In the DÄB message also pointed out an equally entertaining and frustrating Article a former Pharmarefentin that it describes the techniques of the pharmaceutical representatives to leave a positive impression: The paper carries the wonderful title" Following the Script : How Drug Reps Make Friends and Influence Doctors. "Above the article is the set of the Pharmaceutical Representative:
" It's my job to figure out what a physician's price is. For some it's dinner at the finest restaurants, for others it's enough convincing data to let them prescribe confidently and for others it's my attention and friendship ... but . At the most basic level, everything is for sale and everything is an exchange "The overriding conclusion is that initiatives such as MEZIS are important
0 comments:
Post a Comment